Refine by
Stem Cell Derived Equipment & Supplies
38 equipment items found
Manufactured by:Altis Biosystems based inDurham, NORTH CAROLINA (USA)
RepliGut is a unique, human stem cell-derived platform that recreates the intestinal epithelium in a continuous layer of stem and differentiated cells. RepliGut® can be purchased as a product, or Altis Biosystems can provide the services you require. The high throughput platform supports quick screening of ...
Manufactured by:Sana Biotechnology based inSeattle, WASHINGTON (USA)
Diabetes: Type 1 ...
Manufactured by:Stempeutics Research Pvt. Ltd. based inBangalore, INDIA
A novel anti-ageing serum with stem cell derived bioactive factors which promote firm, well moisturized and brighter skin with reduced blemishes and fine ...
Manufactured by:Histocell based inDerio, SPAIN
The HC016 platform is a treatment of acute lung injury, based on mesenchymal stem cells derived from adipose tissue (ASC), improved with proprietary Histocell ...
Manufactured by:Histocell based inDerio, SPAIN
The HC016 platform is a treatment of acute spinal cord injury in the initial stage of the lesion, based on mesenchymal stem cells derived from adipose tissue (ASC), improved with Histocell's proprietary ...
Manufactured by:Celularity Inc. based inFlorham Park, NEW JERSEY (USA)
CYNK-CAR candidates are being developed as allogeneic, off-the-shelf approaches through gene modification of human placental hematopoietic stem cell-derived natural killer (NK) cells. Various CAR constructs against hematological and solid tumor targets are under pre-clinical ...
by:Treefrog Therapeutics based inPessac, FRANCE
C-Stem™ is a biomimetic cell culture technology allowing for the mass-production of stem cell- derived therapies with unprecedented cell quality, while cutting manufacturing costs by 10x. ...
by:The Regeneration Center based inBangkok, THAILAND
Dental pulp stem cells derived (DPSCs) represents a new and exciting alternative source of adult stem cells for use in regenerative medicine. The DPSCs are considered very unique because the cells are relatively easy acquire in an extremely safe and low invasive procedures. During our early ...
Manufactured by:GC Therapeutics Inc. based inCambridge, MASSACHUSETTS (USA)
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed ...
Manufactured by:Jointechlabs Inc. based inNorth Barrington, ILLINOIS (USA)
SVF is a cellular product rich in your own fat-derived stem cells that have been shown to possess powerful anti-inflammatory and immunomodulatory functions. SVF, when injected, helps in the reconstruction, regeneration and healing of ...
Manufactured by:AvantBio Corporation based inLynnwood, WASHINGTON (USA)
Cryopreserve Human Mesenchymal Stem Cells in as little as 1% DMSO. Post-Thaw Viability (A) and 4-day Post-Thaw Proliferation (B, C) of Human Mesenchymal Stems Cells (adipose-derived), Cryopreserved in CRYOVIVE versus Competitor Animal Origin- free Cryogenic Storage Media. ...
by:Treefrog Therapeutics based inPessac, FRANCE
$100,000 Funding: We fund your research over 2 years in the academic lab of your choice. You spend the money how you like on your project, so that you can give it your best shot. Just Science: Any PhD level scientist can apply anonymously by submitting a one-page research rationale and a graphical abstract. We select ideas, not resumes. No Hassle: The application process is fast. We don’t ...
Manufactured by:ROKIT Healthcare based inGeumcheon-gu, SOUTH KOREA
First, INVIVO GEL provides a degree of freedom to tune the elastic modulus (or stiffness) according to user’s specific needs by changing concentration of INVIVO GEL (GELMA) and Gel-linker (A), a photo initiator. Also, by changing UV light (365㎚) exposure time, degree of cross-linking can be adjusted. Second, special INVIVO GEL formulation mimics extracellular ...
Manufactured by:Alphageneron based inCambridge, MASSACHUSETTS (USA)
Chimeric Antigen Receptor (CAR) NK Cells: Alphageneron is developing ‘off-the- shelf’ umbilical cord (UC) blood- and induced pluripotent stem cell (iPSC)-derived CAR-engineered NK (CAR NK) cell-based cancer therapeutics that target tumors expressing mHsp70, and other (undisclosed) targets. Gene ...
Manufactured by:Novadip Biosciences based inMont-Saint-Guibert, BELGIUM
Novadip’s unique “3M3” platform for tissue regeneration combines over 15 years of academic research with practical surgery experience and proof of principle clinical data. ...
by:Valo Health, Inc. based inBoston, MASSACHUSETTS (USA)
Our Biowire II platform applies biomimetic stimulation to produce engineered cardiac tissue with unprecedented adult-like human physiology. Our tissues overcome the limitations of current technology by more accurately & more quickly predicting the efficacy & safety of new medicines in early ...
Manufactured by:Tissue Genesis based inNew Albany, INDIANA (USA)
The Icellator2 system set the standard, providing SVF cell yields in 65 minutes. Currently approved for use in The Bahamas and available in Japan. In the USA, clinical FDA-approved IDE studies using the Icellator® are underway for a variety of ...
Manufactured by:Cartherics Pty ltd based inNotting Hill, AUSTRALIA
This technology involves induced pluripotential stem cell (iPSC) derived NK cells (and, potentially, other types of immune cells). iPSCs have unlimited capacity for ...
Manufactured by:Kangstem Biotech Co., Ltd. based inGangnam-gu, SOUTH KOREA
Kangstem Biotech is developing stem cell therapeutic products for patients suffering from rare and incurable diseases using umbilical cord blood-derived stem ...
Manufactured by:U.S. Stem Cell, Inc. (USRM) based inSunrise, FLORIDA (USA)
Adipose (fat) tissue is readily available and has been shown to be rich in microvascular, myogenic and angiogenic cells. In collaboration with the Regenerative Medicine Institute in Tijuana, Mexico, congestive heart failure patients are being treated in a Phase I/II trial at Hospital Angeles Tijuana. These patients have demonstrated on average an absolute improvement of 13 percentage points in ...